Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
주식 순위 #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
주가
$4.06
마지막 동기화: 2024-02-23
시가총액
$145.61M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Theseus Pharmaceuticals, Inc. (THRX)

카테고리

Theseus Pharmaceuticals, Inc. (THRX)의 주가 이력
최고 종가: $4.07 (2024-02-01 기준)

최저 종가: $16.20 (2021-10-01 기준)
Theseus Pharmaceuticals, Inc.의 주가 이력 (2021 ~ 2026)
연간 주가 성과
연도 성과
2024 5.46%
2023 -30.80%
2022 -54.19%
2021 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH